Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Goodwill (2023 - 2025)

Historic Goodwill for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • bioAffinity Technologies' Goodwill changed 0.0% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.4 million for FY2024, which is 0.0% changed from last year.
  • bioAffinity Technologies' Goodwill amounted to $1.4 million in Q3 2025, which was down 0.0% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Goodwill ranged from a high of $1.4 million in Q4 2023 and a low of $1.1 million during Q3 2023
  • In the last 3 years, bioAffinity Technologies' Goodwill had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • Data for bioAffinity Technologies' Goodwill shows a peak YoY increase of 2228.31% (in 2024) and a maximum YoY decrease of 0.0% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows bioAffinity Technologies' Goodwill stood at $1.4 million in 2023, then changed by 0.0% to $1.4 million in 2024, then changed by 0.0% to $1.4 million in 2025.
  • Its Goodwill stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.